- call +1-201-465-4211
- email sales@mrinsights.biz
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Scope of the Report:
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
There are three type of insulin by resource, it is animal insulin, human insulin, insulin analogue. Animal insulin, because of its side effects, the market share of it is less than 10%, and in the future, the market share will be decrease continually. Human insulin has a larger consumption than insulin analogue, but the side effect is bigger than insulin analogue, so the future market will be occupied by insulin analogue. At the same time, the biggest company producing insulin, Novo Nordisk, has developed a new kind insulin recently, so it will also has a market share in the future.
The worldwide market for Insulin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Animal Insulin
Regular Human Insulin
Insulin Analogue
Market Segment by Applications, can be divided into
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin, with price, sales, revenue and global market share of Insulin in 2017 and 2018.
Chapter 3, the Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Insulin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Animal Insulin
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Market Analysis by Applications
1.3.1 Short acting
1.3.2 Intermediate acting
1.3.3 Long acting
1.3.4 Pre-mix Insulin
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.2 Insulin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novo Nordisk Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Insulin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi-Aventis
2.3.1 Business Overview
2.3.2 Insulin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi-Aventis Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Tonghua Dongbao
2.4.1 Business Overview
2.4.2 Insulin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Tonghua Dongbao Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Ganlee
2.5.1 Business Overview
2.5.2 Insulin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ganlee Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 United Laboratory
2.6.1 Business Overview
2.6.2 Insulin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 United Laboratory Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Jiangsu Wanbang
2.7.1 Business Overview
2.7.2 Insulin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Jiangsu Wanbang Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Insulin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Insulin Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Insulin Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Manufacturer Market Share in 2018
3.3.2 Top 6 Insulin Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Insulin Market Analysis by Regions
4.1 Global Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Sales and Market Share by Regions (2014-2019)
4.1.2 Global Insulin Revenue and Market Share by Regions (2014-2019)
4.2 North America Insulin Sales and Growth Rate (2014-2019)
4.3 Europe Insulin Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Insulin Sales and Growth Rate (2014-2019)
4.5 South America Insulin Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Insulin Sales and Growth Rate (2014-2019)
5 North America Insulin by Country
5.1 North America Insulin Sales, Revenue and Market Share by Country
5.1.1 North America Insulin Sales and Market Share by Country (2014-2019)
5.1.2 North America Insulin Revenue and Market Share by Country (2014-2019)
5.2 United States Insulin Sales and Growth Rate (2014-2019)
5.3 Canada Insulin Sales and Growth Rate (2014-2019)
5.4 Mexico Insulin Sales and Growth Rate (2014-2019)
6 Europe Insulin by Country
6.1 Europe Insulin Sales, Revenue and Market Share by Country
6.1.1 Europe Insulin Sales and Market Share by Country (2014-2019)
6.1.2 Europe Insulin Revenue and Market Share by Country (2014-2019)
6.2 Germany Insulin Sales and Growth Rate (2014-2019)
6.3 UK Insulin Sales and Growth Rate (2014-2019)
6.4 France Insulin Sales and Growth Rate (2014-2019)
6.5 Russia Insulin Sales and Growth Rate (2014-2019)
6.6 Italy Insulin Sales and Growth Rate (2014-2019)
7 Asia-Pacific Insulin by Country
7.1 Asia-Pacific Insulin Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Insulin Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Insulin Revenue and Market Share by Country (2014-2019)
7.2 China Insulin Sales and Growth Rate (2014-2019)
7.3 Japan Insulin Sales and Growth Rate (2014-2019)
7.4 Korea Insulin Sales and Growth Rate (2014-2019)
7.5 India Insulin Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Insulin Sales and Growth Rate (2014-2019)
8 South America Insulin by Country
8.1 South America Insulin Sales, Revenue and Market Share by Country
8.1.1 South America Insulin Sales and Market Share by Country (2014-2019)
8.1.2 South America Insulin Revenue and Market Share by Country (2014-2019)
8.2 Brazil Insulin Sales and Growth Rate (2014-2019)
8.3 Argentina Insulin Sales and Growth Rate (2014-2019)
8.4 Colombia Insulin Sales and Growth Rate (2014-2019)
9 Middle East and Africa Insulin by Countries
9.1 Middle East and Africa Insulin Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Insulin Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Insulin Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Insulin Sales and Growth Rate (2014-2019)
9.3 Turkey Insulin Sales and Growth Rate (2014-2019)
9.4 Egypt Insulin Sales and Growth Rate (2014-2019)
9.5 Nigeria Insulin Sales and Growth Rate (2014-2019)
9.6 South Africa Insulin Sales and Growth Rate (2014-2019)
10 Global Insulin Market Segment by Type
10.1 Global Insulin Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Insulin Sales and Market Share by Type (2014-2019)
10.1.2 Global Insulin Revenue and Market Share by Type (2014-2019)
10.2 Animal Insulin Sales Growth and Price
10.2.1 Global Animal Insulin Sales Growth (2014-2019)
10.2.2 Global Animal Insulin Price (2014-2019)
10.3 Regular Human Insulin Sales Growth and Price
10.3.1 Global Regular Human Insulin Sales Growth (2014-2019)
10.3.2 Global Regular Human Insulin Price (2014-2019)
10.4 Insulin Analogue Sales Growth and Price
10.4.1 Global Insulin Analogue Sales Growth (2014-2019)
10.4.2 Global Insulin Analogue Price (2014-2019)
11 Global Insulin Market Segment by Application
11.1 Global Insulin Sales Market Share by Application (2014-2019)
11.2 Short acting Sales Growth (2014-2019)
11.3 Intermediate acting Sales Growth (2014-2019)
11.4 Long acting Sales Growth (2014-2019)
11.5 Pre-mix Insulin Sales Growth (2014-2019)
12 Insulin Market Forecast (2019-2024)
12.1 Global Insulin Sales, Revenue and Growth Rate (2019-2024)
12.2 Insulin Market Forecast by Regions (2019-2024)
12.2.1 North America Insulin Market Forecast (2019-2024)
12.2.2 Europe Insulin Market Forecast (2019-2024)
12.2.3 Asia-Pacific Insulin Market Forecast (2019-2024)
12.2.4 South America Insulin Market Forecast (2019-2024)
12.2.5 Middle East and Africa Insulin Market Forecast (2019-2024)
12.3 Insulin Market Forecast by Type (2019-2024)
12.3.1 Global Insulin Sales Forecast by Type (2019-2024)
12.3.2 Global Insulin Market Share Forecast by Type (2019-2024)
12.4 Insulin Market Forecast by Application (2019-2024)
12.4.1 Global Insulin Sales Forecast by Application (2019-2024)
12.4.2 Global Insulin Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Insulin Picture
Table Product Specifications of Insulin
Figure Global Sales Market Share of Insulin by Types in 2018
Table Insulin Types for Major Manuf
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
